BIOCRYST PHARMACEUTICALS INC 10-K filing
Filed 2026-02-26 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001628280-26-012240
- Form type
- 10-K
- CIK
- 0000882796
- Primary document
- https://www.sec.gov/Archives/edgar/data/882796/000162828026012240/bcrx-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOCRYST PHARMACEUTICALS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Cost Of Revenue | $19.1M | - | - |
| Operating Income | $341.0M | - | - |
| Net Income | $263.9M | - | - |
| Eps Basic | 1.26 | - | - |
| Eps Diluted | 1.21 | - | - |
| Cash And Equivalents | $89.7M | - | - |
| Total Assets | $514.2M | - | - |
| Total Liabilities | $633.3M | - | - |
| Shareholders Equity | $-119.2M | - | - |
| Operating Cash Flow | $347.4M | - | - |